Paper Details

  1. Home
  2. Paper Details

Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot study.

Author: BigalMarcelo E, RapoportAlan M, SheftellFred D, TepperStewart J

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Daily naratriptan was found to be effective in preventing transformed migraine in patients refractory to other treatments. The treatment was well tolerated with no serious adverse events.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To assess the efficacy, safety, and tolerability of daily naratriptan in the preventive treatment of transformed migraine (TM) refractory to previous first line therapies. BACKGROUND: Limited evidence suggests that the triptans can be used in the preventive treatment of refractory headac...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1526-4610.2005.00273.x

データ提供：米国国立医学図書館（NLM）

Transforming Migraine: Finding Relief in the Storm

Migraines are like a desert storm—sudden, intense, and debilitating. They can disrupt a person's life, making it difficult to function and enjoy everyday activities. For some individuals, migraines become chronic and resistant to traditional treatments, making it even more challenging to find relief. This study explores the potential of daily naratriptan for preventing refractory transformed migraine (TM).

The study included 30 patients with TM who had failed at least two preventive medications. The results showed a significant reduction in headache frequency in all patients who received naratriptan 2.5 mg twice daily. The study also reported excellent tolerability and no serious adverse events. This is like discovering a hidden oasis in the middle of a raging storm—naratriptan offers a potential haven for individuals struggling with refractory migraines.

A New Oasis for Migraine Sufferers

The study suggests that daily naratriptan can be an effective preventive treatment for refractory transformed migraine. It's like finding a hidden spring in the desert—it offers a potential source of relief for individuals struggling with this debilitating condition.

Navigating the Migraine Desert: Finding Relief

The study provides a ray of hope for individuals suffering from refractory transformed migraine. It's like finding a guide to navigate the desert of migraines—naratriptan offers a potential path to relief and improved quality of life.

Dr.Camel's Conclusion

The study demonstrates the potential of daily naratriptan for preventing refractory transformed migraine. It's like finding a desert flower blooming amidst the sand—a beacon of hope for individuals seeking relief from this debilitating condition.

Date :
  1. Date Completed 2006-04-12
  2. Date Revised 2016-11-24
Further Info :

Pubmed ID

16324173

DOI: Digital Object Identifier

10.1111/j.1526-4610.2005.00273.x

Related Literature

Article Analysis
・Effects of naratriptan
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.